§7753. Prohibition of certain discriminatory actions by manufacturer or agent related to 340B entities
1.
Interference with acquisition or delivery of 340B drugs prohibited.
A manufacturer or its agent may not deny, restrict, prohibit or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B contract pharmacy on behalf of a 340B entity unless receipt of that 340B drug is prohibited by the United States Department of Health and Human Services.
[PL 2025, c. 388, Pt. P, §5 (NEW).]
2.
Submission of claims or utilization data prohibited.
A manufacturer or its agent may not, either directly or indirectly, require a 340B entity to submit any claims or utilization data as a condition for allowing the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity unless the claims or utilization data sharing is required by the United States Department of Health and Human Services.
[PL 2025, c. 388, Pt. P, §5 (NEW).]
3.
Other interference prohibited.
A manufacturer may not otherwise interfere directly or indirectly with a 340B entity unless expressly authorized by the United States Department of Health and Human Services.
[PL 2025, c. 388, Pt. P, §5 (NEW).]
SECTION HISTORY
PL 2025, c. 388, Pt. P, §5 (NEW).